Status:
WITHDRAWN
Fractional Laser in Combination With UVB Therapy in Vitiligo Patients
Lead Sponsor:
Netherlands Institute for Pigment Disorders
Conditions:
Vitiligo
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Rationale: Vitiligo is a common skin disorder that can impair a patient's quality of life. Many depigmented lesions in vitiligo patients remain therapy resistant for medical treatment. Therefore new t...
Eligibility Criteria
Inclusion
- Inclusion criteria
- Patients with non segmental (generalised) vitiligo visiting the Netherlands Institute for Pigment Disorders
- receiving NB- UVB treatment for 3 to 6 months
- Age \>18 years
- At least 3 therapy resistant vitiligo lesions on the extremities or trunk larger than 5x5 cm or one vitiligo lesion on the extremities or trunk of at least 5x15 cm.
- Patient is willing and able to give written informed consent
- Exclusion criteria
- Skin type I
- Recurrent HSV skin infections
- Hypertrophic scars
- Keloid
- Cardial insufficiency
- Patients who are pregnant or breast-feeding
- Patients not competent to understand what the procedures involved
- Patients with a personal history of melanoma or non-melanoma skin cancer
- Patients with atypical nevi.
Exclusion
Key Trial Info
Start Date :
May 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2015
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT02290717
Start Date
May 1 2015
End Date
November 1 2015
Last Update
April 18 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Academic Medical Centre
Amsterdam, Netherlands